RS BioTherapeutics

$1.9Mtotal raised · 4 rounds on record
$20klatest round · Venture round · Sep 2024 · 2 yr ago
1-10team · employees, estimated range
2021founded

Funding and backers

Total raised
$1.9M
4 rounds on record
Latest round
$20k
Venture round · Sep 2024 · 2 yr ago
Team
1-10
employees, estimated range
The money's age
Long since its last round
25 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 26, 2024 Raised a round Venture round $20k · SEC Form D Aug 10, 2023 Board appointment David Freas, Director · SEC Form D Jul 20, 2023 Raised a round Venture round $1.1M · SEC Form D Mar 22, 2023 New executive Curtis Rhine, Executive Officer · SEC Form D Nov 16, 2022 Raised a round Venture round $100k · SEC Form D Jun 9, 2022 Raised a round Venture round $685k · SEC Form D 2021 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Sep 2024 $20k — SEC Form D
Venture round Jul 2023 $1.1M — SEC Form D
Venture round Nov 2022 $100k — SEC Form D
Venture round Jun 2022 $685k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity RS BioTherapeutics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Justin MolignoniExecutive Officer, DirectorSEC Form D
Michael GuzmanExecutive OfficerSEC Form D
H. HartExecutive OfficerSEC Form D
Dustin FreasDirectorSEC Form D
Curtis RhineExecutive OfficerSEC Form D

Financials

Total raised
$1.9M
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $20k Details
Venture - Series Unknown 2023 $1.1M Details
Venture - Series Unknown 2022 $100k Details
Venture - Series Unknown 2022 $685k Details

People

Justin Molignoni
Executive Officer, Director
SEC Form D
Michael Guzman
Executive Officer
SEC Form D
H. Hart
Executive Officer
SEC Form D
Dustin Freas
Director
SEC Form D
Curtis Rhine
Executive Officer
SEC Form D
David Freas
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cumberland United States
HQ
1-10 est. staff